Title: Anaesthetic Management of Pregnant patient with severe mitral stenosis and Severe Pulmonary Artery hypertension for cesarean section

Authors: Mahender P, Lailu Mathews, Arun Kumar

 DOI: https://dx.doi.org/10.18535/jmscr/v8i2.155

Abstract

   

Introduction

Cardiac disease in pregnancy poses a unique challenge to the obstetrician and anaesthesiologist. Rheumatic mitral stenosis forms 88% of heart diseases complicating pregnancy in tertiary referral centres in India. The mortality and morbidity are considerably reduced by better perinatal care, where anaesthesiologist plays a major role1. Thecase report of a patient with severe mitral stenosis (MS) and pulmonary artery hypertension (PAH) for elective caesarean section is being presented.

Case Report

A 25year lady (gravida 2, para1, living 1) with MS and PAH (underwent balloon mitral valvotomy six years ago) at 36 weeks of gestation was planned for elective LSCS. She had a previous normal vaginal delivery four years ago which was uneventful. However during the present pregnancyat 33 weeks of gestation, she had dyspnoea at rest and was found to have severe residual stenosis of mitral valve. She was admitted at 34 weeks of gestation with worsening dyspnoea and bilateral pedal oedema suggestive of heart failure. She was managed conservatively with diuretics, beta blockers and cardiac glycosides in the intensive care unit. On examination she was dyspnoeic, heart rate – 68/ min, blood pressure-100/60 mm hg and Spo2 of 98% on room air. Crepitations was present in left apical region. Hematology and biochemistry investigations were within normal limits. Electrocardiogram showed normal sinus rhythm. Transthoracic echocardiogram revealed severe mitral stenosis, tricuspid regurgitation and  severe pulmonary artery hypertension (mitral valve orifice – 0.8 cm2, pulmonary artery systolic pressure -64 mmhg), mitral Valve pressure gradient – 41 mmhg,ejection fraction- 60%). She was on Tab Furosemide 40 mg BD, Tab Digoxin 0.125 mg OD, Tab Metoprolol 12.5 mg BD and Tab Penicillin G 400 mg BD. She was electively posted for caesarean section at 36 weeks of gestation and assessed under ASA III.

References

  1. Kannan M, Vijayaanad G. Mitral stenosis and pregnancy. Current concepts in anaesthetic practice. IOndian J Anaes 2010; 54: 439-444.
  2. Menachem M Weiner, Torsten P. Vhl, Ronald A. Khan. Case Scenario: Cesaren Section complicated by Rheumatic Mitral Stenosis. Anaesthesiology 2011; 114:949-57.
  3. Philip J Balestrieri. The pregnant patient with heart disease. In Chestnut D H. Obstetric anaesthesia: Principles and practice; chapter 40; Mosby Inc 1999.
  4. Mcfaul PB, Dorman JC. Lakmi H et al: Pregnancy complicated by maternal heart disease; A review of 519 cases. Br J of Obst and Gynaec 1988; 95:861.
  5. Kayhan GE, Kacmaz O, Gulhas N, Durmus M. Anaesthesia management for caesarean delivery in a pregnant patient with severe mitral stenosis and pulmonary hypertension. Ann Clin Case Rep. 2016;1:1137.
  6. J, Golwala. M. P., Dhimar. A. A, Swadia. N. Emergency LSCS in a patient with severe Mitral stenosis with Pulmonary Hypertension with Aortic Regurgitation. Indian. J. Anaesth. 2002;46 (6):483-485.
  7. Saxena KN, Wadhwa B, Mishra D. Anaesthetic management of caesarean section in parturients with severe mitral stenosis: A case sries. J ObstetAnaesthCrit Care 2019; 9:46-9.
  8. Batson MA , Longmire S, Csontos E. Alfentanil for urgent caesarean section in a patient with severe mitral stenosis and pulmonary hypertension. Can J Anaesth;37:685-8
  9. Secher NJ, Arnsbo p, Wallin L. Hemodynamic effects of oxytocin and methylergometrineon the systemic and pulmonary circulations of pregnant anaesthetized women. Acta Obstet Gynecol Scand1978;57:97-103.
  10. Hemmings GT, Whalley DG, O’Connor PJ, Benjamin A, Dunn C. Invasive monitoring and anaesthetic management of a parturient with mitral stenosis. Can J Anaesth1987;34:182-5.

Corresponding Author

Mahender P

Junior Resident, Department of Anaesthesiology, Chettinad Hospital and Research Institute, Chennai, India